Chicago, IL - 2016 ASCO Annual Meeting - Otis Brawley, MD, presenting the ASCO-ACS Award to Ethan Dmitrovsky, MD, during ASCO-American Cancer Society Award and Lecture at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Monday, June 6, 2016. Over 30,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 52nd Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Zach Boyden-Holmes 2016 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org
Chicago, IL - 2016 ASCO Annual Meeting - Heritage: A phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus Herceptin during Breast Cancer? HER2/ER Oral Abstract Session at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Monday, June 6, 2016. Over 30,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 52nd Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Brian Powers 2016 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org
